Clinical Trials Browser

Phase 4 × INDUSTRY × abemaciclib × Clear all

NCT04031885 2021-08-24

A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer

Phase 4 Terminated

4 enrolled 9 charts

Breast Neoplasms

NCT03988114 2019-09-06

proMONARCH

Phase 4 Withdrawn

Breast Neoplasms